Management of menorrhagia: an audit of practices in the Anglia menorrhagia education study

Publisher Website
Google Scholar
Abstract
Four audit standards were set with local medical audit advisory groups: all women with menorrhagia under the age of 40 should receive tranexamic acid before hospital referral; no women should receive norethisterone as first line treatment for menorrhagia; all women with menorrhagia should receive tranexamic acid or a non-steroidal anti-inflammatory drug as first line treatment; and women under 40 with menorrhagia should be referred only if appropriate medical treatment had been given. Notes of women aged 15–45 who first attended the year before or after the trial started were identified and audited by the study team. Data analysis calculated odds ratios and 95% confidence intervals with a random effects logistic regression model.5 This model compared the odds of referral or treatment in the intervention group of general practices (n=27) with the control group (n=25), adjusting for pre-intervention behaviour and the cluster randomised design of the original Anglia study.3